Evaxion Biotech A/S (NASDAQ: EVAX) (“Evaxion”), a clinical-stage TechBio company specializing in developing AI-Immunology™ powered vaccines, today announced the pricing of a public offering of an ...

Bristol Myers Squibb today announced the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) has recommended approval of Breyanzi® (lisocabtagene maraleucel; ...

“That’s just a number picked out of thin air,” family law attorney Raiford Dalton Palmer, who is not working on the case, ...

Kindly add us to your ad blocker whitelist ... that a 13,000 square metre facility will be constructed adjacent to MSD’s existing Carlow plant on the Dublin Road. The new expansion is scheduled to ...

We, along with our service providers and other third parties use cookies and other analytics, advertising, and tracking technologies on this site. Your information, including personal information and ...

CONTACT FOR SUBMISSIONS:[email protected] LOS ANGELES, CALIFORNIA / ACCESS Newswire / February 7, 2025 / We pride ourselves on supporting students interested in pursuing a career in law, and to t ...

Documents released under the Official Information Act (OIA) reveal growing tension between the mayor of New Plymouth and the regional boss of the Ministry of Social Development (MSD) over the city ...

Nolan is set to join private bank BDT & MSD Partners after about 13 years of ... Before joining Goldman Sachs, Nolan served as a senior associate at New-York based international law firm Simpson ...

The regulatory agency will review MSD’s new drug application (NDA) for Welireg under a Priority Review, with a Prescription Drug User Fee Act (PDUFA) target action date of 26 May 2025.

Billion in New Commitments Closed in the Fourth Quarter, Reaching a Record of $48.2 Billion Closed in the 12 Months Ended December 31, 2024 NEW YORK, NY / ACCESS Newswire / February 5, 2025 / Ares ...

In a phase 2 trial, an antiretroviral combination developed by Gilead Sciences and MSD suppressed HIV with a single weekly oral dose, raising the hope of a new treatment option for patients.